Results 211 to 220 of about 112,075 (306)

Changing Dynamics in Liver Allocation: Donor and Recipient Traits Pre- and Post Acuity Circle Implementation. [PDF]

Cureus
Fang Y, Nadella J, Yeager M, Sculley D, Bagley D, Alyasiry N, Okeke RI, Rehder J, Nazzal M.   +8 more
europepmc   +1 more source

Advances in Factors and Risk Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt

Portal Hypertension &Cirrhosis, EarlyView.
Hepatic encephalopathy (HE) is a frequent complication that arises subsequent to transjugular intrahepatic portosystemic shunt (TIPS) procedures, with a considerable impact on patient prognosis. The occurrence of HE is influenced by multiple factors, and various risk prediction models have been developed in recent years to forecast its development post‐
Lixin Song, Xinyi Qiao, Yu Sun, Hui Yang
wiley   +1 more source

The Cannabinoid System as a Potential Novel Target for Alcohol-Associated Liver Disease: A Propensity-Matched Cohort Study. [PDF]

Liver Int
Fakhoury B, Jahagirdar V, Rama K, Hudson D, Wang W, Díaz LA, Arab JP.   +6 more
europepmc   +1 more source

Risks and benefits of weaning immunosuppression in liver transplant recipients: Long-term follow-up [PDF]

, 1997
Flynn, B, Fung, JJ, Marino, I, Mazariegos, GV, Reyes, J, Starzl, IE   +5 more
core   +1 more source

Performance of APRI and FIB-4 Scores Compared to FibroScan: A Cross-Sectional Study in a Black Sub-Saharan African Population. [PDF]

Hepat Med
Nsumbu JB, Makulo JR, Mutombo Tshiswaka T, Kisoka Lusunsi C, Nlombi Mbendi C.   +4 more
europepmc   +1 more source

Predictive Value of FVIII and Protein C Levels for Further Decompensated Events in Patients With Decompensated Cirrhosis

Portal Hypertension &Cirrhosis, EarlyView.
Cirrhosis is a major global health burden, the progression to further decompensation is associated with significantly increased mortality. However, the specific predictors of further decompensation in cirrhotic patients remain underexplored. The FVIII/PC ratio has emerged as a significant prognostic marker beyond merely reflecting hypercoagulability in
Siyu Jiang, Sanqiang Wang, Jinsheng Guo, Liyuan Ni, Yingjie Ai, Sitao Ye, Ye Fang, Xiaoquan Huang, Shiyao Chen   +8 more
wiley   +1 more source

Association Between Serum HBV DNA Levels and CCL-20, CD8a, CXCL-16, and GDF-15 in Patients with Chronic Hepatitis B. [PDF]

Viruses
Ezer B, Esen HS, Ugrakli S, Iyisoy MS, Ozdemir M.   +4 more
europepmc   +1 more source

Hepatic fibrosis in patients diagnosed with rheumatoid arthritis and psoriatic arthritis receiving methotrexate: A cross‐sectional analysis using transient elastography

Rheumatology &Autoimmunity, EarlyView.
Hepatic fibrosis and metabolic syndrome are more prevalent in PsA patients treated with methotrexate, compared to RA patients. Metabolic syndrome is associated with the risk of hepatic fibrosis in patients diagnosed with PsA and RA even after adjustment forcumulative methotrexate exposure.
Ratchaya Lertnawapan, Soonthorn Chonprasertsuk, Sith Siramolpiwat, Kanon Jatuworapruk   +3 more
wiley   +1 more source

Liver cirrhosis in 2021: Global Burden of Disease study. [PDF]

PLoS One
Duo H, You J, Du S, Yu M, Wu S, Yue P, Cui X, Huang Y, Luo J, Pan H, Ye Q.   +10 more
europepmc   +1 more source

Novel Wide‐Spectrum Virucidal Lipid Nanoparticles

Small, EarlyView.
POSTAN is a novel broad‐spectrum antiviral nanoparticle that combines safety with potent virucidal activity. Composed of biocompatible lipids, it mimics heparan sulfate proteoglycans and lipid rafts exploited by viruses, thereby dismantling viral envelopes and blocking replication.
Yugo Araújo Martins, Louise Bondeelle, Arnaud Charles‐Antoine Zwygart, Thais Melquiades de Lima, Juliano de Paula Souza, Han Kang Tee, Fernando Chahud, Eurico de Arruda Neto, Francesco Stellacci, Renata Fonseca Vianna Lopez, Caroline Tapparel   +10 more
wiley   +1 more source